Best Peptides for Weight Loss

When evaluating peptides for weight loss, consider these key factors:

• Mechanism of action: Does it suppress appetite, boost metabolism, or both?
• Clinical evidence: Are there peer-reviewed studies supporting its efficacy?
• Safety profile: What are the known side effects?
• Ease of use: Injection frequency and storage requirements matter.

The most effective weight loss peptides typically work through GLP-1 receptor agonism, growth hormone secretion, or a combination of metabolic pathways.

Semaglutide is a GLP-1 receptor agonist that has revolutionized weight management research. Originally studied for type 2 diabetes, clinical trials demonstrated remarkable weight loss results.

Mechanism: Semaglutide mimics the incretin hormone GLP-1, slowing gastric emptying, reducing appetite, and improving insulin sensitivity. It acts on hypothalamic receptors to reduce hunger signaling.

Dosage Range: Research protocols typically start at 0.25 mg/week, titrating up to 2.4 mg/week over 16–20 weeks.

Research Evidence: The STEP trials showed average weight loss of 14.9% of body weight over 68 weeks. Participants also saw improvements in cardiometabolic markers.

Pros:

• Most robust clinical evidence of any weight loss peptide
• Once-weekly dosing
• Significant cardiovascular benefits

Cons:

• GI side effects (nausea, constipation) common during titration
• Requires slow dose escalation
• Weight regain possible after discontinuation

Tirzepatide is a dual GIP/GLP-1 receptor agonist that has shown even greater weight loss potential than semaglutide in head-to-head research.

Mechanism: By activating both GIP and GLP-1 receptors simultaneously, tirzepatide enhances insulin secretion, reduces glucagon, slows gastric emptying, and increases satiety through complementary pathways.

Dosage Range: Research protocols begin at 2.5 mg/week, titrating to 5 mg, 10 mg, or 15 mg/week over several months.

Research Evidence: SURMOUNT-1 trial data showed up to 22.5% body weight reduction at the highest dose over 72 weeks — exceeding semaglutide results.

Pros:

• Highest weight loss efficacy in clinical trials
• Dual mechanism targets multiple pathways
• Strong improvements in metabolic health markers

Cons:

• GI side effects similar to semaglutide
• Newer compound with less long-term safety data
• Higher cost than some alternatives

Ipamorelin is a selective growth hormone secretagogue peptide (GHSP) that promotes fat metabolism through elevated GH levels without the harsh side effects of other GH-releasing peptides.

Mechanism: Ipamorelin selectively stimulates the ghrelin receptor to trigger pulsatile growth hormone release from the pituitary gland. Elevated GH increases lipolysis (fat breakdown) and supports lean body mass preservation during caloric deficit.

Dosage Range: Typical research protocols use 200–300 mcg administered 2–3 times daily via subcutaneous injection, often before bed and fasting.

Research Evidence: Animal and early human studies show ipamorelin increases GH secretion comparable to GHRP-6 but without significant effects on cortisol, prolactin, or appetite stimulation.

Pros:

• Clean GH release without cortisol/prolactin spikes
• Supports fat loss while preserving muscle
• Well-tolerated with minimal side effects

Cons:

• Requires multiple daily injections
• Less dramatic weight loss than GLP-1 agonists
• Best results when combined with exercise and diet

AOD-9604 is a modified fragment of human growth hormone (HGH fragment 176-191) specifically researched for its fat-reducing properties.

Mechanism: AOD-9604 mimics the lipolytic (fat-burning) portion of growth hormone without affecting blood sugar or growth. It stimulates lipolysis and inhibits lipogenesis (fat formation).

Dosage Range: Research protocols typically use 250–500 mcg/day via subcutaneous injection on an empty stomach.

Research Evidence: Clinical studies showed modest but statistically significant fat loss in obese subjects. It received GRAS status from the FDA for oral use in food products.

Pros:

• Targets fat loss specifically without growth effects
• No impact on blood glucose or insulin
• Good safety profile in studies

Cons:

• More modest results than GLP-1 agonists
• Limited large-scale clinical trial data
• Daily injection required

Quality and purity are critical when sourcing research peptides. We recommend Ascension Peptides as a trusted supplier for weight loss peptides. Here's why:

• 99%+ purity verified on all products
• Third-party testing with publicly available certificates of analysis (COAs)
• Fast US shipping with discreet packaging
• Extensive catalog including semaglutide, tirzepatide, ipamorelin, and AOD-9604

As an affiliate partner, we've personally vetted their quality standards. Purity matters — especially with peptides where degradation or contamination can affect results and safety.